NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 33 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 45,849 | $19,000 | 1.30% |
| Aisling Capital Management LP | 191,028 | $80,000 | 0.04% |
| Frazier Life Sciences Management, L.P. | 425,650 | $179,000 | 0.02% |
| Values First Advisors, Inc. | 44,951 | $19,000 | 0.01% |
| Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
| Virtu Financial LLC | 79,556 | $33,000 | 0.00% |
| CCG WEALTH MANAGEMENT, LLC | 10,000 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 26,300 | $11,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 42,738 | $17,000 | 0.00% |